BLUEJAY DIAGNOSTICS INC reports a Return on Equity (ROE) of -165.10%.

What is BJDX's dividend yield?

BLUEJAY DIAGNOSTICS INC offers a dividend yield of 0.00%.

What is BJDX's Quality Score?

Our AI rates BJDX's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy BJDX?

Our AI Timing Score for BJDX is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does BJDX belong to?

BLUEJAY DIAGNOSTICS INC is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange

BJDX (NASDAQ) Stock Analysis | BLUEJAY DIAGNOSTICS INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

BJDX AI Analysis Summary

Our AI summary for BJDX: BLUEJAY DIAGNOSTICS INC (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 0.00, ROE of -165.10%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

BJDX

BLUEJAY DIAGNOSTICS INC

US:NASDAQ STOCK Healthcare >> Medical Devices News 90

USD 0.86

-0.07 (-7.46%) Day Change

Watchlist Portfolio Compare Chart

0.02

D/E

-165.1%

ROE

-123.3%

ROA

0.00%

Div Yield

BLUEJAY DIAGNOSTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.86 Price -0.07 (-7.46%) Day Change	NEWS SCORE: 90

BJDX, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

47%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	90
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.86
PBV / Sector	0.23 / -101.57 GREAT
Earning Per Share	-6.17

PE / Sector	N/A / 31.23
PEG or PE/Growth / Sector	N/A / 0.40
Average 1M Daily Value	11.05 M GREAT
Average 1W Daily Value	0.22 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

43%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 20.50
NPM Average (%) / Sector	-3,733.11 / -15.37
NPM Change Average (%) / Sector	N/A / 7.34
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-123.30 / 39.11
ROA Average (%) / Sector	-121.73 / 5.58
ROA Change Average (%) / Sector	41.30 / 104.50 GREAT
ROE (%) / Sector	-165.10 / -166.42
ROE Average (%) / Sector	-167.76 / -16.93
ROE Change Average (%) / Sector	73.79 / -500.08 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.43
Dividend Average (%) / Sector	0.01 / 1.85
Dividend Change Average (%) / Sector	N/A / 3.44

Registration Details

Analyze Date	2026-08-01 07:59:33
Symbol	BJDX
Name	BLUEJAY DIAGNOSTICS INC
Sector	Healthcare >> Medical Devices
Market	NASDAQ
Listed Shares	1.03 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	0.96 / 20,104.97

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 360 Massachusetts Avenue, Acton, MA, United States, 01720

Phone: 844 327 7078

Website: https://bluejaydx.com

Sector: Healthcare >> Medical Devices

Description: Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.